Control Bionics offers a suite of dedicated speech generating devices and AAC accessories to give people living with complex communication and physical needs their voice. Our product range is more intuitive and flexible than ever, giving users the power to make life-changing connections. Control Bionics makes NeuroNode, a sixth generation computer-human-interface (CHI) system that is designed to enable people with severe disabilities to communicate with their loved ones, carers, friends and the world at large with text, text-to-speech (TTS), instant messaging (IM), emails and the internet; and to control their own entertainment media (music, videos and online services) as well as expanding their own creativity with word processing, music and video editing, and design programs.
External link for Control Bionics (ASX:CBL)
697 Burke Rd
Lvl 5, Suite 5.01
Camberwell, Victoria 3124, AU
MILFORD, OH 45150, US
Control Bionics (ASX:CBL) reposted this
I enjoyed sitting down with Paul Sanger and the team at Finance News Network this week to discuss the strong six months Control Bionics (ASX:CBL) has had. We had the chance to talk about our recent success in the US and Europe and the outlook for FY25. We're looking forward to sharing further news in the coming months. https://lnkd.in/gY4VM_fX
Thanks for the coverage Stockhead! Jeremy Steele David Falk Lindsay Phillips Roger Hawke Joe Durak Kanak Sahasrabudhe Adi Deshpande
Control Bionics inks UK and Ireland distribution deal for NeuroNode https://buff.ly/4cYizND #ASX #ASX200 $CBL Control Bionics (ASX:CBL)
🎉Big news for Control Bionics! We're excited to announce our exclusive distribution agreement with Smartbox Assistive Technology, the UK’s leading assistive technology provider! This partnership allows us to expand the reach of our innovative NeuroNode® device into the UK and Ireland, empowering people with Motor Neurone Disease (#MND), cerebral palsy, and other neurological disorders. Key highlights: ✅ Exclusive distribution by Smartbox Ltd. ✅ Access to Smartbox’s strong network of healthcare professionals. ✅ Strengthened presence in the European market. We’re confident this partnership will accelerate the adoption of NeuroNode® and improve the quality of life for countless individuals with speech and motor impairments. 💪 #ControlBionics #NeuroNode #AssistiveTechnology #Smartbox #CerebralPalsy #Innovation #UK #Ireland Jeremy Steele Roger Hawke Peter S Ford David Falk Lindsay Phillips Joe Durak Kanak Sahasrabudhe Adi Deshpande
We're thrilled to share that our CEO and Managing Director, Jeremy Steele, recently sat down with Stockhead to discuss a significant milestone for Control Bionics—achieving a new US insurance code for our groundbreaking NeuroNode technology! 🎉 This achievement is a game-changer, enabling Medicare and Medicaid to reimburse $4,300 for each NeuroNode device, starting from 1st October this year. This recognition not only highlights the value of our technology but also opens up new opportunities for individuals who need it most to access this life-changing device. 🌍 Global Impact: Our NeuroNode technology has already transformed thousands of lives across the USA, Australia, and Japan. With our sights set on expanding into Europe and the UK, we're eager to bring this Australian made innovation to even more people worldwide. 💡 Innovations in Motion: We're not stopping at the NeuroNode. Jeremy also shared insights on our other cutting-edge products: > DROVE Autonomous Wheelchair Module: Empowering individuals to independently navigate their homes. > NeuroStrip: Advancing our EMG technology to detect muscle activity with unparalleled precision, with our first customers in sports science. At Control Bionics, we’re committed to pushing the boundaries of assistive technology to improve lives globally. Watch the full interview here: https://lnkd.in/gpRdE-aR Interview with Jeremy Steele and learn more about our journey and future plans. Roger Hawke David Falk Lindsay Phillips Kerry Series Joe Durak Kanak Sahasrabudhe Adi Deshpande #ControlBionics #AssistiveTechnology #NeuroNode #Innovation #Healthcare #Technology
Our very own Jeremy Steele recently sat down with #AusbizTV to discuss the impact of our significant strategic milestone - US government approval for a new insurance code. This approval means our NeuroNode can now reach more people across the US, with coverage potential from Medicare, Medicaid, and even private insurance. It’s a significant step forward, ensuring that those who need our technology most can access it more easily. As Jeremy explained during the interview, getting a device approved for Medicare and Medicaid is no small feat—it’s a process that can take years. This is a huge achievement for Control Bionics, and we couldn't be more excited about the possibilities it opens up for the future! 🎥 Watch the full interview here https://lnkd.in/g3q8Kxaj #ControlBionics #MedTech #NeuroNode #Innovation #HealthcareTech #Medicare #Medicaid #AssistiveTechnology Roger Hawke Peter S Ford David Falk Lindsay Phillips Kerry Series Joe Durak Kanak Sahasrabudhe Adi Deshpande
Control Bionics (ASX:CBL) reposted this
CBL lifts on NeuroNode’s approval as reimbursable medical device in US https://buff.ly/4cySy7a #ASX #ASX200 $CBL #controlbionics
Excited for the future of those who need the NeuroNode and the possibility of an easier funding journey in the future! It takes a committed team and patience to make an impact in the funding world, but we did it!!
📢 We’re thrilled to announce a significant strategic milestone with the approval of a new US Insurance Code Approved for our flagship technology, the NeuroNode®. This pivotal approval means the NeuroNode® is now officially recognised as a reimbursable medical device in the US, opening doors to a US$4,300 reimbursement that was previously unavailable. What does this mean? Once this becomes effective on 1 October 2024: 🌟 It results in a material benefit to the business’ operations in the US. 🌟 Represents a substantial opportunity to expand our wholesale distribution model as part of our ‘NeuroNode® Only’ strategy. 🌟 Both Control Bionics and our US partners will be able to apply for this reimbursement for customers covered by Medicare and Medicaid, and we’ll also work to have it covered ‘in-network’ with private insurers. This milestone accelerates our growth trajectory and strengthens our commitment to improving lives through innovative assistive technology. We look forward to the opportunities this new approval will bring! Roger Hawke Jeremy Steele Peter S Ford David Falk Kerry Series Lindsay Phillips Joe Durak Kanak Sahasrabudhe Adi Deshpande #ControlBionics #NeuroNode #ASX #HealthcareInnovation #MedTech #Medicare #Medicaid #USHealthcare #AssistiveTechnology
📢 We’re thrilled to announce a significant strategic milestone with the approval of a new US Insurance Code Approved for our flagship technology, the NeuroNode®. This pivotal approval means the NeuroNode® is now officially recognised as a reimbursable medical device in the US, opening doors to a US$4,300 reimbursement that was previously unavailable. What does this mean? Once this becomes effective on 1 October 2024: 🌟 It results in a material benefit to the business’ operations in the US. 🌟 Represents a substantial opportunity to expand our wholesale distribution model as part of our ‘NeuroNode® Only’ strategy. 🌟 Both Control Bionics and our US partners will be able to apply for this reimbursement for customers covered by Medicare and Medicaid, and we’ll also work to have it covered ‘in-network’ with private insurers. This milestone accelerates our growth trajectory and strengthens our commitment to improving lives through innovative assistive technology. We look forward to the opportunities this new approval will bring! Roger Hawke Jeremy Steele Peter S Ford David Falk Kerry Series Lindsay Phillips Joe Durak Kanak Sahasrabudhe Adi Deshpande #ControlBionics #NeuroNode #ASX #HealthcareInnovation #MedTech #Medicare #Medicaid #USHealthcare #AssistiveTechnology
🌟 Don’t miss Jeremy Steele's latest interview with OnImpact Media. As the CEO of Control Bionics, he offers impact investors valuable insights into how we empower individuals with complex communication and physical needs to interact with the world. 👉 Read the full interview here: https://lnkd.in/gMSepr64 Meagan Evans Kerry Series Roger Hawke Peter S Ford David Falk Lindsay Phillips Joe Durak Kanak Sahasrabudhe Adi Deshpande #AssistiveTechnology #Innovation #ControlBionics #Leadership
📺 Check out Jeremy Steele's recent TV interview on Ausbiz where he discusses the strategic investment from NorthStar Impact Fund and the value of this new partnership. Jeremy also shared an overview of our mission to empower individuals with disabilities, our unique technology, and AI's role in our innovations. It's a great watch for anyone interested in the intersection of technology, innovation, and positive societal impact. 👉 Watch the full interview https://lnkd.in/g4Ufy_8B #ControlBionics #Innovation #AI #AssistiveTechnology #Ausbiz #ImpactInvesting Roger Hawke Peter S Ford Kerry Series Lindsay Phillips David Falk Joe Durak Kanak Sahasrabudhe Adi Deshpande Elvira Badke